This article ties to SDG 3. This clinical review article, published in Hematology/Oncology Clinics, presents current understanding of the pathogenesis for each subtype of CD as of 2017. Although understanding of CD has slowly improved over the last 6 decades, leading to improved patient survival and quality of life, additional research is needed. The authors anticipate significant progress to be made in the coming years through research studies led by the CDCN, including the ACCELERATE (Advancing Castleman Care with an Electronic Longitudinal registry, E-Repository, And Treatment/Effectiveness research) Natural History Registry (www.CDCN.org/ACCELERATE), which is open for patient self-enrollment.
Elsevier, Smart Wheelchairs and Brain-computer Interfaces: Mobile Assistive Technologies, Volume , 1 January 2018
Smart Wheelchairs and Brain-Computer Interfaces: Mobile Assistive Technologies combines the fields of neuroscience, rehabilitation and robotics via contributions from experts in their field to help re
Electronic Assistive Technology (EAT) is a subset of a wider range of products and services known as Assistive Technology (AT).
Objectives Gender identity disorder is defined as a strong and persistent cross-gender identification that is associated with a remarkable uneasiness of living in an incongruent gender (gender dysphor
Ethnopharmacological relevance In the Peruvian Amazon, the use of medicinal plants is a common practice.
Among the different pharmaceuticals present in soil and water ecosystems as micro-contaminants, considerable attention has been paid to antibiotics, since their increasing use and the consequent devel
A human-centered design thinking approach has been applied to a course at the MIT D-Lab on creating low-cost prosthetic and assistive devices for the developing world.
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in mortality due to hepati
In 2016, WHO adopted a strategy for the elimination of viral hepatitis by 2030.
Background Multistage, stepwise HIV testing and treatment procedures can result in lost opportunities to provide timely antiretroviral therapy (ART).
